retatrutide study results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a phase 2 study: • Up to 24.2% mean weight loss at 48 weeks Retatrutide: What It Is &

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus

If your BMI (Body Mass Index) is above 30 or its above 27 and you ALSO have an additional health condition like sleep apnea, high cholesterol or high blood pressure, you may qualify for the help of one of these medications

I feel incredibly fortunate to have joined the MDWatch program and to have been paired with my nurse practitioner, Kristi Richards

Pricing Disclaimer: All prices, program details, and terms mentioned were accurate based on publicly available information at the time of publication (March 2026) and are subject to change without notice

Macronutrient blends expanded at a 14.1% CAGR through 2030